John Maraganore is CEO of an increasingly rare breed of firm—the innovative science-based biotech.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Negotiating the RNAi patent thicket
Companies eye slice of age-related macular degeneration market
Silent running: the race to the clinic
Web links
Rights and permissions
About this article
Cite this article
Huggett, B. Profile: John Maraganore. Nat Biotechnol 25, 375–376 (2007). https://doi.org/10.1038/nbt0407-375
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0407-375
- Springer Nature America, Inc.
This article is cited by
-
The economics of licensing contracts
Bioentrepreneur (2008)